Search results
Millions of Americans need drugs like Ozempic. Will it bankrupt the health care system?
The Columbian· 12 hours agoAn April 24 letter from Vermont Sen. Bernie Sanders to the CEO of Novo Nordisk began with heartfelt...
Early blood glucose control for people with type 2 diabetes
Digital Journal· 35 minutes agoThe data drawn from UKPDS represents the largest clinical evidence relating to diabetes yet...
Moderna’s stock climbs on report that bird-flu vaccine funding is near
Market Watch· 3 days agoThe funding from the Biomedical Advanced Research and Development Authority, an office within the...
Wegovy users have less kidney-related health problems, analysis of Novo study finds
StreetInsider· 7 days agoThe analysis, from a large study for which substantial results had been released by...European Renal Congress in Stockholm. "By addressing key markers of kidney health, semaglutide ...
Novo Nordisk defends $1,000 Ozempic list price
Becker’s Hospital Review· 6 days agoNovo Nordisk is contesting Sen. Bernie Sanders' calls to reduce the list prices of Ozempic and Wegovy in the U.S., Bloomberg reports. This followed research showing that Ozempic could be manufactured ...
S&P 500 Giants Lead Five Healthy Stocks Near Buy Points
Investor's Business Daily· 1 day agoEli Lilly, Novo Nordisk, Vertex Pharmaceuticals, Intuitive Surgical and Universal Health are all...
Goldman Sachs Says Buy European Pharma Stocks Touting Innovation
Bloomberg via Yahoo Finance· 4 days ago(Bloomberg) -- European drugmakers that are focused on building portfolios of new medicines have...
The FDA is weighing whether to approve MDMA for PTSD. Here's what that could look like for patients.
CBS News· 2 days agoDetails of the FDA's proposal were published Friday in a set of documents released by the agency...
Novartis sues Maryland over law prohibiting restrictions on 340B drugs
Becker’s Hospital Review· 3 days ago"Novartis sues Maryland over new law restricting 340B drug pricing program, citing conflict with federal law and potential harm to constitutional rights."
US FDA panel votes against Novo Nordisk's weekly insulin in type 1 diabetes patients
StreetInsider· 7 days agoThe comments come after the FDA's staff on Wednesday flagged the risk of low blood sugar in type 1 diabetes patients, who are more insulin-dependent, and the lack of clinical ...